Talon Therapeutics, Inc. (TLON) 1.68 0.15 (9.80%) 3:59PM EDT
Trading 4 X the daily average volume today!
(FDA) approval coming in less than 18 days for their lead drug !
Short term price target is $4.50
Marqibo® (vincristine sulfate liposome injection, OPTISOME™) A Novel Targeted Nanoparticle-encapsulated Anti-Cancer Compound currently for Acute Lymphoblastic Leukemia (ALL) and Melanoma. Marqibo® has a robust safety database (over 600 patients) and has been extensively evaluated in lymphoid blood cancers such as non-Hodgkin’s lymphoma (NHL) and ALL. Talon has ongoing (or planned) clinical trials which may enable an accelerated approval in 2 indications. Future clinical trial development possible in multiple indications including NHL and melanoma. More Details »
Alocrest™ (vinorelbine liposomes injection, OPTISOME™) A Novel Targeted Anti-Cancer Compound for Breast and Lung Cancer. Alocrest™ has completed a Phase I dose-escalation trial demonstrating promising anti-cancer activity as well as acceptable and predictable toxicity. More Details »
Brakiva™ (topotecan liposomes injection, OPTISOME™) A Novel Targeted Anti-Cancer Compound for Small-Cell Lung Cancer and Ovarian Cancer. Preclinical data demonstrate the value of Brakiva™ over conventional topotecan. More Details »
Menadione Topical Lotion - A Topical Compound for Skin Rash Associated with EGFR Inhibitors. Treatment with EGFR inhibitors such as Tarceva®, Erbitux® and Vectibix® are associated with an acne-form rash involving the face, neck and upper torso in approximately 75% patients. 50% of patients who manifest skin toxicity experience significant discomfort. This results in drug discontinuation or dose reduction in at least 10% and up to 30% of all subjects. Drug delivery is targeted to the normal location of the EGFR-containing skin cells at the dermal/epidermal junction without interfering with EGFR inhibition systemically at the level of the tumor.
Very nice post.. Fully expect TLON to break $2s this week and go onto hitting $3+ before approval comes. Blue sky breakout here, next big thing in biotech. Remember where ARNA came from --- $1-2 -- then above $13 -- same can happen here, this drug pipeline is more efficient than Arenas just without the hype. Expect some massive volume to come in and BULL raid this stock. I'm long TLON. Also playing AMRN FDA approval tomorrow. Taking my profits here IMHO ..